June 2021 - Page 38 of 42

ThursdayJun 03, 2021 9:00 am

FingerMotion Inc. (FNGR) Big Data Insights Arm, Sapientus, Represents Future Potential For Data-Driven Solutions Amid Shortfall of Data Experts

FingerMotion (OTCQX: FNGR) a mobile data and services company, is developing additional value-added technologies to expand its user base to over 1 billion users in China and other regional markets FingerMotion’s Data Insights platform Sapientus delivers data-driven solutions to the insurance and financial services industries Sapientus entered into a services agreement with Pacific Life Re, a global life reinsurer to deliver more efficient and customized solutions to the wider insurance ecosystem FingerMotion (OTCQX: FNGR) is a mobile payment and recharge platform serving markets in China, evolving rapidly by using core competencies. With offices in Hong Kong, Shanghai, and New York,…

ThursdayJun 03, 2021 9:00 am

Friendable Inc. (FDBL) Implements 120-Day Strategy as Fan Pass Prepares for v2 Release

Friendable has ten successful months of growth with the Fan Pass platform, including an increase of 188% in new artist sign-ups since the beginning of the year. The company will be shifting all attention to its Fan Pass platform The global streaming video market was valued at $50.11 billion in 2020. This number is expected to grow at a CAGR of 21% through 2028. Over the next 120 days and through the remainder of 2021, mobile technology and marketing company Friendable (OTC: FDBL) will be implementing a new strategy designed to ensure sustained and continued growth, consisting of the launch…

ThursdayJun 03, 2021 9:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Targets Academic Collaborations to Advance Research on Largely Ignored Indications for Psilocybin

Psychedelics have been on the receiving end of groundbreaking research, which have greatly influenced the medical acceptance of the compounds Pharmaceutical developer Tryp Therapeutics is looking to use existing preclinical and clinical data to proceed directly to Phase 2a clinical trials The company intends to contribute to the growing body of research through academic collaborations with leading American institutions The research will focus on indications that other pharmaceutical companies have largely ignored Although we can accurately describe the psychedelics industry as nascent, psychedelics have been the subject of a flurry of groundbreaking research that have gradually lifted the stigma surrounding…

WednesdayJun 02, 2021 1:38 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Nears Dosing of Phase 2 Patients with Standout Anthracycline Therapy

CNS Pharmaceuticals (NASDAQ: CNSP) is focused on producing a treatment that improves on the effectiveness of established chemotherapy drug lomustine in increasing overall survival rates of glioblastoma multiforme (“GBM”) patients. GBM is an illness that is nearly 100% fatal in patients just over a year after diagnosis. CNS Pharmaceuticals’ lead drug candidate, Berubicin, has been granted investigational new drug (“IND”) status after promising findings. “Berubicin is a standout anthracycline therapy because of its novel apparent ability to cross the blood-brain barrier to combat neurological tumors. The drug was the subject of a Phase I trial some 15 years ago in…

WednesdayJun 02, 2021 1:22 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Building Strong Commercial Pipeline for Unique PeDAL(TM) Platform

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, continues to create value for a growing customer base through its subsidiaries. Researchers from one such subsidiary, Helomics, recently completed key sequencing milestones for ovarian cancer to help build its AI-driven models of the disease. “We are building a strong commercial pipeline for our unique Patient-cEntric Discovery by Active Learning (PeDAL)(TM), which we launched at the beginning of 2021,” POAI CEO J. Melville Engle was quoted in a recent article. “PeDAL brings together the key Helomics assets of real-world longitudinal data…

WednesdayJun 02, 2021 12:56 pm

QualityStocksNewsBreaks – Perpetual Industries Inc. (PRPI) Featured in Video Interview as Incubator of Innovation, Bringing Bright Ideas to Life

Perpetual Industries’ (OTC: PRPI) CEO Brent Bedford was featured in a recent video interview where he provided an overview of PRPI’s business strategy and a closer look at two projects the company is involved in. “PRPI is designed to be an incubator for the development of innovative, energy-efficient technologies aimed at commercializing products that have the potential to impact and advance a wide range of industries on a global scale,” reads a recent article discussing the company. “Everybody knows somebody that is a crazy inventor out there, right?” said Bedford during the video interview, now available on the company’s YouTube…

WednesdayJun 02, 2021 12:11 pm

QualityStocksNewsBreaks – FingerMotion Inc. (FNGR) Releases Financial Results for FYE 2021

FingerMotion (OTCQX: FNGR), a mobile services and data company, has released its financial results for the fiscal year ending Feb. 28, 2021. A highlight of the report was record annual revenue of $16.68 million, which includes the company’s SMS (“SMS”) & MMS (“MMS”) and telecommunications products and services. That total represents an estimated 82% increase from FYE 2020. Other financial numbers worth noting include annual growth in SMS & MMS business revenue of $6.13 million, or 84% compared to the same period the year before; annual growth in telecommunications products and services business revenue of $1.39 million, or a 76%…

WednesdayJun 02, 2021 12:01 pm

QualityStocksNewsBreaks – Chalice Brands Ltd. (CSE: CHAL) (OTCQB: GLDFF) Announces OTC Ticker Symbol Change Effective June 3, 2021

Chalice Brands (CSE: CHAL) (OTCQB: GLDFF), formerly Golden Leaf Holdings Ltd., a premier consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, today announced a change in the company's stock symbol trading on the OTCQB(R) Venture Market. According to the update, the company's common shares will trade on the OTCQB under the symbol "CHALF" effective June 3, 2021. The previous trading symbol was "GLDFF." To view the full press release, visit https://ibn.fm/3igfR About Chalice Brands Ltd. Chalice Brands is a premier consumer-driven cannabis company specializing in production, processing, wholesale, distribution, and retail, with 12 dispensaries in Portland, Oregon.…

WednesdayJun 02, 2021 11:52 am

QualityStocksNewsBreaks – Friendable Inc.’s (FDBL) Fan Pass Sees Stellar Month Prior to Unveiling Several New Features

Friendable (OTC: FDBL), a mobile technology and marketing company, today announced certain performance and growth metrics for its Fan Pass livestreaming artist platform for the month of May 2021. According to the update, May has delivered another stellar month of traction in several categories as the company prepares to release its 2.0 version of the Fan Pass platform. “These next several months are going to lead us to and eventually through our version 2 mobile and web app releases, which will include an entirely new suite of features, virtual currency options, automation and, ultimately, scale,” said Friendable CEO Robert A.…

WednesdayJun 02, 2021 11:47 am

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) to Present at Upcoming H.C. Wainwright Psychedelics Conference

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW), a pharmaceutical company focused on developing compounds for diseases with unmet medical needs through accelerated regulatory pathways, has announced that it will be presenting at H.C. Wainwright & Co.’s Psychedelics in Psychiatry and Beyond conference. The virtual event will be held on June 17, 2021. At the elite conference, Tryp chair and CEO Greg McKee will present an overview of the business including the company’s pipeline, which features its psilocybin-for-neuropsychiatric disorders, or PFN(TM) (“PFN”), program for chronic pain and eating disorder indications. McKee’s prerecorded presentation will be available beginning 7 a.m. EDT…

Site Search

Company Search

Month: June 2021

FingerMotion Inc. (FNGR) Big Data Insights Arm, Sapientus, Represents Future Potential For Data-Driven Solutions Amid Shortfall of Data Experts

Friendable Inc. (FDBL) Implements 120-Day Strategy as Fan Pass Prepares for v2 Release

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Targets Academic Collaborations to Advance Research on Largely Ignored Indications for Psilocybin

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Nears Dosing of Phase 2 Patients with Standout Anthracycline Therapy

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Building Strong Commercial Pipeline for Unique PeDAL(TM) Platform

QualityStocksNewsBreaks – Perpetual Industries Inc. (PRPI) Featured in Video Interview as Incubator of Innovation, Bringing Bright Ideas to Life

QualityStocksNewsBreaks – FingerMotion Inc. (FNGR) Releases Financial Results for FYE 2021

QualityStocksNewsBreaks – Chalice Brands Ltd. (CSE: CHAL) (OTCQB: GLDFF) Announces OTC Ticker Symbol Change Effective June 3, 2021

QualityStocksNewsBreaks – Friendable Inc.’s (FDBL) Fan Pass Sees Stellar Month Prior to Unveiling Several New Features

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) to Present at Upcoming H.C. Wainwright Psychedelics Conference

Market Basics

Newsletter Publishers

Public Companies